Multipotent adult progenitor cells sustain function of ischemic limbs in mice

Journal of Clinical Investigation

Volumn 118, Issue 2, 2008, Pages 505-514

  Aranguren, Xabier L ^a,b   McCue, Jonathan D ^c   Hendrickx, Benoit ^d   Zhu, Xiao Hong ^c   Du, Fei ^c   Chen, Eleanor ^c   Pelacho, Beatriz ^b,c   Peñuelas, Ivan ^b   Abizanda, Gloria ^b   Uriz, Maialen ^b   Frommer, Sarah A ^c   Ross, Jeffrey J ^c   Schroeder, Betsy A ^c   Seaborn, Meredith S ^c   Adney, Joshua R ^c   Hagenbrock, Julianna ^c   Harris, Nathan H ^c   Zhang, Yi ^c   Zhang, Xiaoliang ^c   Nelson Holte, Molly H ^c,d   Jiang, Yuehua ^c   Billiau, An D ^d   Chen, Wei ^c   Prósper, Felipe ^b   Verfaillie, Catherine M ^c,d   Luttun, Aernout ^a,c   more..

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT STEM CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; CELL DIFFERENTIATION; CELL POPULATION; GERM LAYER; INTERMITTENT CLAUDICATION; LIMB ISCHEMIA; LIMB PERFUSION; MALE; MOUSE; MUSCLE DEVELOPMENT; MUSCLE FUNCTION; MUSCLE GROWTH; MUSCLE REGENERATION; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; SMOOTH MUSCLE FIBER; TISSUE REGENERATION; VASCULAR SMOOTH MUSCLE; VASCULARIZATION;

ANIMALS; BLOOD VESSELS; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; EXTREMITIES; HUMANS; ISCHEMIA; MALE; MICE; MICE, INBRED C57BL; MULTIPOTENT STEM CELLS; MUSCLE CELLS;

EID: 38849199383     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI31153     Document Type: Article

References (48)

1. Collinson, D.J., and Donnelly, R. 2004. Therapeutic angiogenesis in peripheral arterial disease: can biotechnology produce an effective collateral circulation? Eur. J. Vasc. Endovasc. Surg. 28:9-23.
2. Norgren, L., et al. 2007. Inter-society consensus for the management of peripheral arterial disease (TASC II). J. Vasc. Surg. 45(Suppl. S):S5-S67.
3. Makinen, K., et al. 2002. Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study. Mol. Ther. 6:127-133.
4. Rajagopalan, S., et al. 2003. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation. 108:1933-1938.
5. Jeon, O., et al. 2006. Synergistic effect of sustained delivery of basic fibroblast growth factor and bone marrow mononuclear cell transplantation on angiogenesis in mouse ischemic limbs. Biomaterials. 27:1617-1625.
6. Asahara, T., et al. 1997. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 275:964-967.
7. Ikenaga, S., et al. 2001. Autologous bone marrow implantation induced angiogenesis and improved deteriorated exercise capacity in a rat ischemic hindlimb model. J. Surg. Res. 96:277-283.
8. Kinnaird, T., et al. 2004. Local delivery of marrowderived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation. 109:1543-1549.
9. Kupatt, C., et al. 2005. Embryonic endothelial progenitor cells expressing a broad range of proangiogenic and remodeling factors enhance vascularization and tissue recovery in acute and chronic ischemia. FASEB J. 19:1576-1578.
10. Madeddu, P., et al. 2004. Transplantation of low dose CD34+KDR+ cells promotes vascular and muscular regeneration in ischemic limbs. FASEB J. 18:1737-1739.
11. Nakagami, H., et al. 2005. Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissuederived stromal cells. Arterioscler. Thromb. Vasc. Biol. 25:2542-2547.
12. Niagara, M.I., et al. 2004. Autologous skeletal myoblasts transduced with a new adenoviral bicistronic vector for treatment of hind limb ischemia. J. Vasc. Surg. 40:774-785.
13. Pesce, M., et al. 2003. Myoendothelial differentiation of human umbilical cord blood-derived stem cells in ischemic limb tissues. Circ. Res. 93:e51-e62.
14. Dimmeler, S., Zeiher, A.M., and Schneider, M.D. 2005. Unchain my heart: the scientific foundations of cardiac repair. J. Clin. Invest. 115:572-583.
15. Emmerich, J. 2005. Current state and perspective on medical treatment of critical leg ischemia: gene and cell therapy. Int. J. Low. Extrem. Wounds. 4:234-241.
16. Heng, B.C., Cao, T., Haider, H.K., Rufaihah, A.J., and Sim, E.K. 2005. Utilizing stem cells for myocardial repair-to differentiate or not to differentiate prior to transplantation? Scand. Cardiovasc. J. 39:131-134.
17. Urbich, C., et al. 2005. Cathepsin L is required for endothelial progenitor cell-induced neovascularization. Nat. Med. 11:206-213.
18. Torrente, Y., et al. 2004. Human circulating AC133 (+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. J. Clin. Invest. 114:182-195.
19. Lamagna, C., and Bergers, G. 2006. The bone marrow constitutes a reservoir of pericyte progenitors. J. Leukoc. Biol. 80:677-681.
20. Shimizu, K., et al. 2001. Host bone-marrow cells are a source of donor intimal smooth- muscle-like cells in murine aortic transplant arteriopathy. Nat. Med. 7:738-741.
21. Urbich, C., and Dimmeler, S. 2004. Endothelial progenitor cells: characterization and role in vascular biology. Circ. Res. 95:343-353.
22. Jiang, Y., et al. 2002. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 418:41-49.
23. Reyes, M., et al. 2002. Origin of endothelial progenitors in human postnatal bone marrow. J. Clin. Invest. 109:337-346.
24. Ross, J.J., et al. 2006. Cytokine-induced differentiation of multipotent adult progenitor cells into functional smooth muscle cells. J. Clin. Invest. 116:3139-3149.
25. Waters, R.E., Terjung, R.L., Peters, K.G., and Annex, B.H. 2004. Preclinical models of human peripheral arterial occlusive disease: implications for investigation of therapeutic agents. J. Appl. Physiol. 97:773-780.
26. Luttun, A., et al. 2002. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat. Med. 8:831-840.
27. Shim, J.Y., and Kim, T.S. 2003. Relationship between utrophin and regenerating muscle fibers in Duchenne muscular dystrophy. Yonsei Med. J. 44:15-23.
28. Salimena, M.C., Lagrota-Candido, J., and Quirico-Santos, T. 2004. Gender dimorphism influences extracellular matrix expression and regeneration of muscular tissue in mdx dystrophic mice. Histochem. Cell Biol. 122:435-444.
29. Heil, M., and Schaper, W. 2004. Influence of mechanical, cellular, and molecular factors on collateral artery growth (arteriogenesis). Circ. Res. 95:449-458.
30. Andersson, G., et al. 2003. Engraftment of retroviral EGFP-transduced bone marrow in mice prevents rejection of EGFP-transgenic skin grafts. Mol. Ther. 8:385-391.
31. Ulloa-Montoya, F., et al. 2007. Comparative transcriptome analysis of embryonic and adult stem cells with extended and limited differentiation capacity. Genome Biol. 8:R163.
32. Li, T.S., et al. 2002. Improved angiogenic potency by implantation of ex vivo hypoxia prestimulated bone marrow cells in rats. Am. J. Physiol. Heart Circ. Physiol. 283:H468-H473.
33. Grunewald, M., et al. 2006. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell. 124:175-189.
34. Shi, D., Reinecke, H., Murry, C.E., and Torok-Storb, B. 2004. Myogenic fusion of human bone marrow stromal cells, but not hematopoietic cells. Blood. 104:290-294.
35. Huss, R., et al. 2004. Improved arteriogenesis with simultaneous skeletal muscle repair in ischemic tissue by SCL (+) multipotent adult progenitor cell clones from peripheral blood. J. Vasc. Res. 41:422-431.
36. Di Rocco, G., et al. 2006. Myogenic potential of adipose-tissue-derived cells. J. Cell Sci. 119:2945-2952.
37. Koike, N., et al. 2004. Tissue engineering: creation of long-lasting blood vessels. Nature. 428:138-139.
38. Finney, M.R., et al. 2006. Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemia. Biol. Blood Marrow Transplant. 12:585-593.
39. Tateno, K., et al. 2006. Critical roles of muscle-secreted angiogenic factors in therapeutic neovascularization. Circ. Res. 98:1194-1202.
40. Kalka, C., et al. 2000. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. U. S. A. 97:3422-3427.
41. Kocher, A.A., et al. 2001. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7:430-436.
42. Zentilin, L., et al. 2006. Bone marrow mononuclear cells are recruited to the sites of VEGF-induced neovascularization but are not incorporated into the newly formed vessels. Blood. 107:3546-3554.
43. Hamano, K., et al. 2001. The induction of angiogenesis by the implantation of autologous bone marrow cells: a novel and simple therapeutic method. Surgery. 130:44-54.
44. Shintani, S., et al. 2001. Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation. 103:897-903.
45. Traggiai, E., et al. 2004. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science. 304:104-107.
46. Aranguren, X.L., et al. 2007. In vitro and in vivo arterial differentiation of human multipotent adult progenitor cells. Blood. 109:2634-2642.
47. Seaman, W.E., Sleisenger, M., Eriksson, E., and Koo, G.C. 1987. Depletion of natural killer cells in mice by monoclonal antibody to NK-1.1. Reduction in host defense against malignancy without loss of cellular or humoral immunity. J. Immunol. 138:4539-4544.
48. Ytrehus, K., et al. 1994. Rat and rabbit heart infarction: effects of anesthesia, perfusate, risk zone, and method of infarct sizing. Am. J. Physiol. 267:H2383-H2390.